Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12485350rdf:typepubmed:Citationlld:pubmed
pubmed-article:12485350lifeskim:mentionsumls-concept:C2698565lld:lifeskim
pubmed-article:12485350lifeskim:mentionsumls-concept:C0037549lld:lifeskim
pubmed-article:12485350lifeskim:mentionsumls-concept:C0083381lld:lifeskim
pubmed-article:12485350lifeskim:mentionsumls-concept:C0743223lld:lifeskim
pubmed-article:12485350lifeskim:mentionsumls-concept:C0013125lld:lifeskim
pubmed-article:12485350lifeskim:mentionsumls-concept:C0060502lld:lifeskim
pubmed-article:12485350pubmed:issue6lld:pubmed
pubmed-article:12485350pubmed:dateCreated2002-12-17lld:pubmed
pubmed-article:12485350pubmed:abstractTextThree nonsteroidal anti-inflammatory drugs (NSAIDs) [sodium salicylate, flunixin (FLU) and meloxicam (MEL)] were administered intravenously to broiler chickens. Plasma concentrations were determined by high-performance liquid chromatography methods and pharmacokinetic parameters were calculated. After intravenous administration of sodium salicylate (50 mg/kg), FLU (1.1 mg/kg) and MEL (0.5 mg/kg), these drugs were eliminated from plasma with a mean half-life of 04.04, 05.45 and 03.20 h, respectively. Apparent volumes of distribution (0.39, 0.08 and 0.12 L/kg, respectively) indicated that tissue distribution was limited for the three drugs. Total body clearance was 70 mL/h.kg for sodium salicylate and 10 and 25 mL/kg.h for FLU and MEL, respectively. Based on the pharmacokinetic parameters these NSAIDs may offer possibilities for treatment of various conditions in chickens.lld:pubmed
pubmed-article:12485350pubmed:languageenglld:pubmed
pubmed-article:12485350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:citationSubsetIMlld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12485350pubmed:statusMEDLINElld:pubmed
pubmed-article:12485350pubmed:monthDeclld:pubmed
pubmed-article:12485350pubmed:issn0140-7783lld:pubmed
pubmed-article:12485350pubmed:authorpubmed-author:De BackerPPlld:pubmed
pubmed-article:12485350pubmed:authorpubmed-author:BaertKKlld:pubmed
pubmed-article:12485350pubmed:issnTypePrintlld:pubmed
pubmed-article:12485350pubmed:volume25lld:pubmed
pubmed-article:12485350pubmed:ownerNLMlld:pubmed
pubmed-article:12485350pubmed:authorsCompleteYlld:pubmed
pubmed-article:12485350pubmed:pagination449-53lld:pubmed
pubmed-article:12485350pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:meshHeadingpubmed-meshheading:12485350...lld:pubmed
pubmed-article:12485350pubmed:year2002lld:pubmed
pubmed-article:12485350pubmed:articleTitleDisposition of sodium salicylate, flunixin and meloxicam after intravenous administration in broiler chickens.lld:pubmed
pubmed-article:12485350pubmed:affiliationDepartment of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. kris.baert@rug.ac.belld:pubmed
pubmed-article:12485350pubmed:publicationTypeJournal Articlelld:pubmed